When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AZN - AstraZeneca/Oxford COVID-19 vaccine candidate shows robust action in early-stage study
AstraZeneca PLC
Results from a 508-subject Phase 1 clinical trial, just published online in The Lancet, showed that AstraZeneca's (AZN-0.1%) COVID-19 vaccine candidate showed a seroconversion rate at high as 97% at day 28.
More news on: AstraZeneca PLC, Oxford Biomedica plc, Healthcare stocks news, Stocks on the move,